反应 #2823

ord-28db859784404afd8675d326cead07a5

反应方程式

C1COCCN1
Morpholine
CCCCC(=O)Nc1ccc(C(=O)O)cc1[N+](=O)[O-]
3-nitro-4-valeramidobenzoic acid
C(=NC1CCCCC1)=NC1CCCCC1
Dicyclohexylcarbodiimide
On1nnc2ccccc21
1-hydroxybenzotriazole
CCCCC(=O)Nc1ccc(C(=O)N2CCOCC2)cc1[N+](=O)[O-]
3-nitro-4-valeramidobenzoic acid morpholide

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    workup.STIRRINGThe mixture was stirred for 16 hours
  2. 2
    其他After the insolubles were removed from the reaction solution
  3. 3
    浓缩the solution was concentrated
  4. 4
    其他dried
  5. 5
    workup.DISSOLUTIONThe crude product was dissolved in chloroform
  6. 6
    其他the insolubles were removed
  7. 7
    其他the solution was purified by silica gel column chromatography (Kieselgel 60=400 g, chloroform/methanol=30/1)
  8. 8
    其他to obtain the compound ([1]-(12)-1) (22.95 g) as yellow needle crystals

实验过程

In tetrahydrofuran (800 ml), 3-nitro-4-valeramidobenzoic acid ([1]-(11)-1) (20.0 g) was dissolved. Dicyclohexylcarbodiimide (17.1 g) and 1-hydroxybenzotriazole (11.2 g) were added to the solution, and the mixture was stirred at room temperature for 15 minutes. Morpholine (7.27 g) was further added to the solution. The mixture was stirred for 16 hours. After the insolubles were removed from the reaction solution, the solution was concentrated and dried. The crude product was dissolved in chloroform, and the insolubles were removed, and the solution was purified by silica gel column chromatography (Kieselgel 60=400 g, chloroform/methanol=30/1) to obtain the compound ([1]-(12)-1) (22.95 g) as yellow needle crystals.

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US05731310uspto-grants-1998_03